Aldeyra Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.59

+0.07 (+4.61%)

As of May 9, 1:54 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +2,615.7% upside

Low Target $31.72

Average Target $43.18

High Target $59.84

Current Price $1.59

Current
$1.59

Target
$43.18

$31.72 $43.18 avg $59.84

Scenario Analysis

Bear Case

$31.72

1,895.0%

Low target

Base Case

$43.18

+2,615.7%

Avg target

Bull Case

$59.84

+3,663.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.18

-74.3% from high

52-Week Low

$1.07

+48.6% from low

Target vs 52W High

$43.18

+599.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%